Evaluation of PET/MRI Using a Somatostatin Analog Tracer as a Novel Approach to Detecting Pathology in High Risk TB-exposed Contacts

NCT02967666 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis, Pulmonary

Interventions

RADIATION: FDG ligand
RADIATION: DOTANOC ligand

Sponsor

National University Hospital, Singapore